Tao‐Wei Ke
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Co-authors
- William Tzu‐Liang Chen (48 shared papers)K. S. Clifford Chao (30 shared papers)Shu‐Fen Chiang (29 shared papers)William Tzu-Liang Chen (15 shared papers)Kevin Chih‐Yang Huang (29 shared papers)Tsung-Wei Chen (18 shared papers)Ya‐Wen Cheng (5 shared papers)Ying‐Shu You (5 shared papers)
In The Last Decade
Tao‐Wei Ke
82 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 87
- Oncology 741
- Cancer Research 305
- Immunology 355
- Gastroenterology 87
- Physiology 41
Countries citing papers authored by Tao‐Wei Ke
This map shows the geographic impact of Tao‐Wei Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao‐Wei Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao‐Wei Ke more than expected).
Fields of papers citing papers by Tao‐Wei Ke
This network shows the impact of papers produced by Tao‐Wei Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao‐Wei Ke. The network helps show where Tao‐Wei Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Tao‐Wei Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 129 | |
| 2 | 2011 | 118 | |
| 3 | 2014 | 101 | |
| 4 | 2020 | 74 | |
| 5 | 2017 | 62 | |
| 6 | 2018 | 52 | |
| 7 | 2019 | 45 | |
| 8 | 2016 | 44 | |
| 9 | 2014 | 39 | |
| 10 | 2022 | 38 | |
| 11 | 2018 | 38 | |
| 12 | 2013 | 31 | |
| 13 | 2014 | 30 | |
| 14 | 2021 | 30 | |
| 15 | 2020 | 27 | |
| 16 | 2021 | 27 | |
| 17 | 2022 | 26 | |
| 18 | 2024 | 25 | |
| 19 | 2016 | 25 | |
| 20 | 2021 | 24 |
About Tao‐Wei Ke
Tao‐Wei Ke is a scholar working on Oncology, Surgery, Immunology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 90 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (28 papers), Cancer Immunotherapy and Biomarkers (22 papers), Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (14 papers), Colorectal and Anal Carcinomas (14 papers), Genetic factors in colorectal cancer (10 papers), Colorectal Cancer Screening and Detection (10 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Oncology (741 citations), Cancer Research (305 citations), Immunology (355 citations), Gastroenterology (87 citations) and Physiology (41 citations). Tao‐Wei Ke has collaborated with scholars based in Taiwan, China and Austria. Frequent co-authors include William Tzu‐Liang Chen, K. S. Clifford Chao, Shu‐Fen Chiang, William Tzu-Liang Chen, Kevin Chih‐Yang Huang, Tsung-Wei Chen, Ya‐Wen Cheng, Ying‐Shu You, Po‐Li Wei and Chen‐Yu Lin. Their work appears in journals such as Anticancer Research, Surgical Endoscopy, Cancer Immunology Immunotherapy, Scientific Reports and Diseases of the Colon & Rectum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.